Komori
Results6298Y.A.C.HOLDINGS CO.,LTD.Machinery

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)

During the interim period, net sales decreased 1.2% year on year and operating profit fell 38.1%, while interim net income attributable to owners of the parent turned to a loss of ¥35 million. The full-year earnings forecast remains unchanged, and the annual dividend forecast will increase from the previous fiscal year's actual dividend of ¥40 to ¥45.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
38.1
% (year-on-year decline in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAP
Net Sales12,690¥ millionYear on year -1.2%Progress 36.3%
Operating profit478¥ millionYear on year -38.1%Progress 14.5%
Ordinary income258¥ millionYear on year -60.7%Progress 8.6%
Net income attributable to owners of the parent-35¥ millionYear on year -109.5%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share-¥2.00
Financial position at period-end
Total assets44,024¥ million
of which net assets 16,433 ¥ millionEquity ratio 37.2%vs. prior year-end -1.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueSemiconductor and Mechatronics-Related Business ¥5,447 million (YoY +9.4%), Medical and Healthcare-Related Business ¥2,346 million (YoY -15.6%), Environmental and Social Infrastructure-Related Business ¥4,896 million (YoY -3.9%)
Segment profitSemiconductor and Mechatronics-Related Business ¥498 million (YoY -33.3%), Medical and Healthcare-Related Business ¥4 million (YoY -96.8%), Environmental and Social Infrastructure-Related Business ¥408 million (YoY +34.3%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥35,000 million (YoY +32.3%)
Operating profit¥3,300 million (YoY +150.0%)
Ordinary income¥3,000 million (YoY +145.6%)
Profit attributable to owners of the parent¥2,000 million (YoY +50.8%)
Revision to Earnings ForecastNo (unchanged)
Annual Dividend Forecast¥40 → ¥45(+12.5%)
Factors Behind Changes in Business Performance

The shift in the timing of revenue recognition to the second half or later, mainly for large projects; higher raw material and procurement costs; changes in the product mix; and lower sales in the medical and healthcare-related businesses.

Disclosure regarding the going concern assumption

There are no applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNewly included: 0 companies; excluded: 0 companies. 株式会社GDテック changed its fiscal year-end from 31 December to 31 March.
Material subsequent eventsEffective 1 October 2026, an absorption-type merger will be carried out with the consolidated subsidiary ワイエイシイメカトロニクス株式会社 as the surviving company and ワイエイシイマシナリー株式会社 and 株式会社ワイエイシイダステック as the absorbed companies. The purpose is to integrate the Group's technologies, customer bases and human resources and deploy management resources in growth areas. The impact on consolidated results will be minor.
Impairment lossNot applicable
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million, Other ¥0 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥2 million, Office relocation expenses ¥20 million, System-disruption response costs ¥17 million / Total special losses ¥39 million
Depreciation and amortization¥152 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End19,517,894 shares
Treasury Shares at Period-End1,931,293 shares
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026–30 September 2026
Net Sales¥12,690 million (YoY -1.2%)
Operating profit¥478 million (YoY -38.1%)
Ordinary income¥258 million (YoY -60.7%)
Profit attributable to owners of the parent¥-35 million (YoY -109.5%)
Net income per share-¥2.00
Equity ratioEnd of the current fiscal period 37.2 / End of previous period 38.7
Total assets¥44,024 million
Net assets¥16,433 million
Full-year earnings forecastNet Sales ¥35,000 million (YoY +32.3%) / Operating profit ¥3,300 million (YoY +150.0%) / Ordinary income ¥3,000 million (YoY +145.6%) / Profit attributable to owners of the parent ¥2,000 million (YoY +50.8%)
Revision to Earnings ForecastNo (unchanged)
Annual Dividend Forecast¥40 → ¥45(+12.5%)
Segment revenueSemiconductor and Mechatronics-Related Business ¥5,447 million (YoY +9.4%), Medical and Healthcare-Related Business ¥2,346 million (YoY -15.6%), Environmental and Social Infrastructure-Related Business ¥4,896 million (YoY -3.9%)
Segment profitSemiconductor and Mechatronics-Related Business ¥498 million (YoY -33.3%), Medical and Healthcare-Related Business ¥4 million (YoY -96.8%), Environmental and Social Infrastructure-Related Business ¥408 million (YoY +34.3%)
Depreciation and amortization¥152 million
Impairment lossNot applicable
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million, Other ¥0 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥2 million, Office relocation expenses ¥20 million, System-disruption response costs ¥17 million / Total special losses ¥39 million
Disclosure regarding the going concern assumptionThere are no applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNewly included: 0 companies; excluded: 0 companies. 株式会社GDテック changed its fiscal year-end from 31 December to 31 March.
Material subsequent eventsEffective 1 October 2026, an absorption-type merger will be carried out with the consolidated subsidiary ワイエイシイメカトロニクス株式会社 as the surviving company and ワイエイシイマシナリー株式会社 and 株式会社ワイエイシイダステック as the absorbed companies. The purpose is to integrate the Group's technologies, customer bases and human resources and deploy management resources in growth areas. The impact on consolidated results will be minor.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End19,517,894 shares
Treasury Shares at Period-End1,931,293 shares
Factors Behind Changes in Business PerformanceThe shift in the timing of revenue recognition to the second half or later, mainly for large projects; higher raw material and procurement costs; changes in the product mix; and lower sales in the medical and healthcare-related businesses.
Items this document does not state (9)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reasons cited were the shift in the timing of revenue recognition to the second half or later, mainly for large projects, higher raw material and procurement costs, changes in the product mix, and lower sales in the medical and healthcare-related businesses.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.